Current and historical daily PE Ratio for Virbac SA (
) from 2008 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Virbac stock (LTS:0NM7) PE ratio as of Jun 20 2024 is 24.25.
More Details
Virbac SA (LTS:0NM7) PE Ratio (TTM) Chart
Virbac SA (LTS:0NM7) PE Ratio (TTM) Historical Data
View and export this data going back to 2008. Start your Free Trial
Total 1277
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Virbac PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | 24.0 | 2024-04-16 | 25.0 |
2024-06-19 | 24.0 | 2024-04-15 | 25.0 |
2024-06-18 | 24.2 | 2024-04-12 | 25.3 |
2024-06-17 | 23.5 | 2024-04-11 | 25.0 |
2024-06-14 | 23.4 | 2024-04-10 | 24.6 |
2024-06-13 | 23.9 | 2024-04-09 | 25.0 |
2024-06-12 | 24.6 | 2024-04-08 | 25.0 |
2024-06-11 | 24.5 | 2024-04-05 | 24.9 |
2024-06-10 | 25.0 | 2024-04-04 | 24.8 |
2024-06-07 | 25.2 | 2024-04-03 | 24.1 |
2024-06-06 | 25.8 | 2024-04-02 | 23.4 |
2024-06-05 | 25.0 | 2024-03-28 | 24.1 |
2024-06-04 | 24.3 | 2024-03-27 | 23.6 |
2024-06-03 | 24.6 | 2024-03-26 | 24.0 |
2024-05-31 | 24.8 | 2024-03-25 | 24.2 |
2024-05-30 | 24.6 | 2024-03-22 | 24.1 |
2024-05-29 | 24.4 | 2024-03-21 | 23.7 |
2024-05-28 | 24.6 | 2024-03-20 | 22.9 |
2024-05-24 | 25.1 | 2024-03-19 | 23.6 |
2024-05-23 | 25.1 | 2024-03-18 | 23.5 |
2024-05-22 | 25.2 | 2024-03-15 | 23.0 |
2024-05-21 | 24.8 | 2024-03-14 | 23.5 |
2024-05-20 | 24.3 | 2024-03-13 | 23.7 |
2024-05-17 | 24.6 | 2024-03-12 | 23.6 |
2024-05-16 | 25.0 | 2024-03-11 | 23.7 |
2024-05-15 | 25.6 | 2024-03-08 | 23.7 |
2024-05-14 | 25.4 | 2024-03-07 | 23.5 |
2024-05-13 | 24.9 | 2024-03-06 | 23.2 |
2024-05-10 | 24.8 | 2024-03-05 | 23.2 |
2024-05-09 | 24.7 | 2024-03-04 | 23.3 |
2024-05-08 | 24.6 | 2024-03-01 | 23.6 |
2024-05-07 | 24.3 | 2024-02-29 | 23.3 |
2024-05-03 | 24.7 | 2024-02-28 | 23.7 |
2024-05-02 | 24.1 | 2024-02-27 | 23.6 |
2024-05-01 | 24.2 | 2024-02-26 | 23.8 |
2024-04-30 | 24.2 | 2024-02-23 | 24.0 |
2024-04-29 | 24.3 | 2024-02-22 | 24.3 |
2024-04-26 | 24.1 | 2024-02-21 | 24.0 |
2024-04-25 | 24.2 | 2024-02-20 | 24.2 |
2024-04-24 | 25.1 | 2024-02-19 | 24.1 |
2024-04-23 | 24.9 | 2024-02-16 | 24.2 |
2024-04-22 | 25.1 | 2024-02-15 | 24.0 |
2024-04-19 | 25.9 | 2024-02-14 | 23.9 |
2024-04-18 | 26.1 | 2024-02-13 | 23.5 |
2024-04-17 | 25.7 | 2024-02-12 | 23.6 |
Virbac SA (LTS:0NM7) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Virbac SA
ISIN : FR0000031577
Compare
Compare
Traded in other countries / regions
VIRP.France0NM7.UKVRBCF.USAV16.Germany IPO Date
2008-01-09Description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.